Patent: 4,447,355
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,447,355
Title: | Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same |
Abstract: | A method for stabilizing a Tumor Necrosis Factor (TNF), which comprises adding at least one member selected from the group consisting of an albumin, a gelatin, a globulin, a protamine and a salt of protamine to an aqueous solution or powder containing TNF, and a stable aqueous solution or powder which contains TNF and an effective amount of such a protein. The aqueous solution or powder containing TNF can be stored for a prolonged period of time without losing its activity, and is stable on freezing, thawing, lyophilization or the like. |
Inventor(s): | Sakamoto; Hajimu (Fuji, JP), Kiyota; Takao (Fuji, JP), Hayashi; Hiroshi (Fuji, JP) |
Assignee: | Asahi Kasei Kogyo Kabushiki Kaisha (Osaka, JP) Dainippon Pharmaceutical Co., Ltd. (Osaka, JP) |
Application Number: | 06/477,866 |
Patent Claims: | see list of patent claims |
Details for Patent 4,447,355
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2002-04-07 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2002-04-07 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2002-04-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |